145 related articles for article (PubMed ID: 6414693)
1. Ifosfamide--current aspects and perspectives.
Hilgard P; Herdrich K; Brade W
Cancer Treat Rev; 1983 Sep; 10 Suppl A():183-92. PubMed ID: 6414693
[No Abstract] [Full Text] [Related]
2. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
Retsas S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Matthiessen W; Stempinski E; Göbel D; Thalmann U
Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
[No Abstract] [Full Text] [Related]
4. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
Pratt CB
Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
[TBL] [Abstract][Full Text] [Related]
5. Continuously improving ifosfamide/mesna: a winning combination.
Anderson P
Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
[No Abstract] [Full Text] [Related]
6. Severe renal failure following high-dose ifosfamide and mesna.
Willemse PH; de Jong PE; Elema JD; Mulder NH
Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557).
Klein HO; Wickramanayake PD; Christian E; Coerper C
Cancer; 1984 Sep; 54(6 Suppl):1193-203. PubMed ID: 6432305
[TBL] [Abstract][Full Text] [Related]
8. Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
Hilgard P; Burkert H
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1451-2. PubMed ID: 6437825
[No Abstract] [Full Text] [Related]
9. Ifosfamide, mesna, and encephalopathy.
Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
[No Abstract] [Full Text] [Related]
10. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
Stuart-Harris RC; Harper PG; Parsons CA; Kaye SB; Mooney CA; Gowing NF; Wiltshaw E
Cancer Chemother Pharmacol; 1983; 11(2):69-72. PubMed ID: 6414732
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide in the treatment of soft tissue sarcomas.
Connelly EF; Budd GT
Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
[TBL] [Abstract][Full Text] [Related]
12. Irreversible encephalopathy with ifosfamide/mesna.
Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
[No Abstract] [Full Text] [Related]
13. Ifosfamide/mesa and encephalopathy.
Cantwell BM; Harris AL
Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
[No Abstract] [Full Text] [Related]
14. The role of ifosfamide in paediatric cancer.
Advani SH
Aust N Z J Med; 1998 Jun; 28(3):410-3. PubMed ID: 9673760
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.
Focan C; Le Hung S; Bays-Gallaix R; Frère MH; Demonceau G; Mbuyamba P; Salamon E; Claessens JJ
Cancer Treat Rev; 1983 Sep; 10 Suppl A():159-61. PubMed ID: 6684990
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide and ifosfamide: role of uroprotective agents.
Williams SD; Munshi N; Einhorn LH; Loehrer PJ
Cancer Invest; 1990; 8(2):269. PubMed ID: 2119246
[No Abstract] [Full Text] [Related]
17. Interstitial pneumonitis associated with ifosfamide therapy.
Baker WJ; Fistel SJ; Jones RV; Weiss RB
Cancer; 1990 May; 65(10):2217-21. PubMed ID: 2112039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
Scheulen ME; Niederle N; Bremer K; Schütte J; Seeber S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():93-101. PubMed ID: 6414700
[TBL] [Abstract][Full Text] [Related]
19. High-dose ifosfamide alone and in combination for solid malignancies in childhood.
Gasparini M
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S18. PubMed ID: 3102090
[No Abstract] [Full Text] [Related]
20. Infusion of ifosfamide plus mesna.
Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
